Calcium channel blockers, HMG CoA reductase inhibitors, agents acting on the renin-angiotensin system, antithrombotic agents, diuretics, beta blocking agents, salicylic acid and its derivatives, drugs used in diabetes, and vasodilators used in cardiac diseases were linked to an increased LAS risk. This evidence concerns the gene HMGCR and heart disorder.